Oncolytics Biotech (ONCY) Misses Q3 EPS by 2c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• U.S. and Denmark close in on a Greenland deal - Reuters
• Enablence closes C$25M private placement with Collingwood Investments
• Axion Minerals plans flow-through private placement of up to $440K